The Chemours Co (NYSE: CC) has reported earnings for its second fiscal quarter (ending June 30) of $0.47 versus a loss $-2.52 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $0.77 versus $-0.66 for the same period a year ago.
Recent Price Action
The Chemours Co (NYSE: CC) stock declined by -3.6% on 8/1/24. The shares closed at $23.31. This decline was accompanied by normal trading volume. The stock has been weak relative to the market over the last nine months and has declined -0.8% during the last week.
Current PriceTarget Research Rating
CC’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Chemours has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Chemours has a neutral Appreciation Score of 56 but a very low Power Rating of 5, leading to the Lowest Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment